Literature DB >> 15172075

Automatic screening in postmortem toxicology.

T Stimpfl1, W Vycudilik.   

Abstract

The systematic analysis of postmortem samples is one of the most challenging tasks in forensic toxicology. For determining cause of death, analysis of different tissues can be indispensable. Automation of these analyses would increase reproducibility and therefore lead to more reliable and comparable results. Recent developments in analytical toxicology and the availability of automation devices for various analytical stages, such as sampling, preliminary testing, sample extraction, chromatographic separation, identification, and data processing are examined and discussed. At present only parts of the analytical procedure have been automated-however, the goal should be the integration of these parts into a single, continuous process. Currently, only one "fully-automated" procedure for the comprehensive screening of blood and urine (excluding sample pretreatment, which remains separate) has been published. But it can be expected that automation of analytical procedures in forensic toxicology will indeed progress, even with regard to the very complex screening of postmortem samples.

Entities:  

Mesh:

Year:  2004        PMID: 15172075     DOI: 10.1016/j.forsciint.2004.02.014

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  2 in total

1.  Fast gradient elution reversed-phase liquid chromatography with diode-array detection as a high-throughput screening method for drugs of abuse. II. Data analysis.

Authors:  Sarah E G Porter; Dwight R Stoll; Changyub Paek; Sarah C Rutan; Peter W Carr
Journal:  J Chromatogr A       Date:  2006-10-27       Impact factor: 4.759

2.  Comprehensive automation of the solid phase extraction gas chromatographic mass spectrometric analysis (SPE-GC/MS) of opioids, cocaine, and metabolites from serum and other matrices.

Authors:  Oliver Lerch; Oliver Temme; Thomas Daldrup
Journal:  Anal Bioanal Chem       Date:  2014-05-02       Impact factor: 4.142

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.